Facebook
Twitter
LinkedIn
Google+
ForwardPost-Thrombotic Syndrome [CME] (CONG2014-25)
This course includes the following:
Epidemiology
Eberhard Rabe, MD
Diagnosis Assessment Skills
Joseph Caprini, MD, MS, FACS, RVT
Economic Impact
Thomas O'Donnell, MD
Advanced Imaging
Neil Khilnani, MD, FACPh
Preventing and Treatment of PTS
Thomas O'Donnell, MD
Evidence-Based Compression Therapy and PTS
Hugo Partsch, MD, FACPh
Case Studies: Phlegmasia Cerulea Alba, Phlegmasia Cerulea Dolens and Venous Gangrene
Joseph Caprini, MD, MS, FACS, RVT
Question and Answer
All Faculty
Steps to Successfully Complete This Activity
To participate in this educational activity please follow the steps listed below.
If you are new to the ACP Online Education Center we require that you register prior to viewing any activity. Click the Register link located in the top right corner of this screen to do so. If you are already a registered user log in and click the TAKE COURSE button that will appear in the Course Summary box.
- To begin the activity click the START COURSE button.
- Progress through course content by using the NEXT button.
- Complete all required items in the course.
- Participants must score 80% or greater on the Post-Test to advance and receive credit. They are given three attempts to meet this threshold.
- Track your progress using the Course Progress menu.
- On the final page of the activity a link will be provided to download your certificate.
Target Audience
The content of this activity is designed to meet the needs of the following target audience: phlebologists, general surgeons, vascular surgeons, interventional radiologists, interventional cardiologists, vascular medicine practitioners, dermatologists, dermatologic surgeons, family practice and internal medicine practitioners, plastic surgeons, obstetricians and gynecologists, cardiologists, and any other healthcare professional currently or planning on treating patients with venous disease.
Learning Objectives
As a result of this activity the participant should be able to:
- Explain the CEAP score, venous disease severity score, adn the Villalta score.
- Describe why post-thrombotic syndrome is a complex, multifaceted abnormality deserving evaluation by more than a single score.
- Cite evidence regarding the efficiency of compression therapy in preventing post-thrombotic syndrome based on previous and recent randomized controlled trials.
- Describe the reasons for discrepant results in recent post-thrombotic syndrome trials.
| NAME | ROLE | COMMERCIAL INTEREST | TYPE OF RELATIONSHIP |
|---|---|---|---|
| Joseph Caprini, MD, MS, FACS, RVT | Moderator; Speaker | Pfizer Sanofi Poland | Consultant Speaker |
| Yung-Wei Chi, DO, FAHA, FSVM | Planner | None | n/a |
| Neil Khilnani, MD, FACPh | Speaker | Sapheon | Consultant |
| Sanjoy Kundu, MD, FSIR, FASA, DABR, FCIRSE | Content Reviewer | None | n/a |
| Margaret Mann, MD | Content Reviewer | BTG (Varithena) | Consultant; Advisory Board |
| Michelle McEvoy, RN, MSN/Ed | Content Reviewer | None | n/a |
| Stephen H. Moss | Staff | None | n/a |
| Diana L. Neuhardt, RVT, RPhS | Content Reviewer | BTG | Speaker |
| Thomas O'Donnell, MD | Speaker | Tactile Medical | Consultant |
| Hugo Partsch, MD, FACPh | Speaker | Tactile Medical | Consultant |
| Eberhard Rabe, MD | Speaker | None | n/a |
| Sherry Scovell, MD | Content Reviewer | None | n/a |
| Saundra Spruiell, DO, FACPh, RPVI | Planner | None | n/a |
| Sonja Stiller-Martin, MD | Content Reviewer | None | n/a |
| Robert Worthington-Kirsch, MD, FSIR, FCIRSE, FACPh, RVT, RPVI | Content Reviewer | None | n/a |
Disclaimer
The views and opinions expressed in this activity are those of the faculty and do not necessarily represent the views of the ACP. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting professional use of any of the information provided herein. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of ACP Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.
Discussion of Off-Label Use
Although no longer required by the Accreditation Council for Continuing Medical Education (ACCME), ACP CME requests all faculty to inform learners of any products they will discuss that are off-label or investigational.
Reproduction Prohibited
Reproduction of this material is not permitted without written permission from the copyright owner.
Review & Recertification
This course was reviewed and recertified for AMA PRA Category 1 CreditTM in November 2016.
Available Credit
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Attendance